Bacterial fusion proteins containing portions of the Bunyamwera virus L protein were used as immunogens to prepare antisera in rabbits. Of five fusion proteins injected into rabbits, three yielded sera that reacted with the Bunyamwera virus L protein, detected by Western blotting or immunoprecipitation. Two of these antisera were specific for either the amino-or carboxy-terminal regions of the L protein. The specificity of these antisera was confirmed by their pattern of reactivity with full-length and truncated forms of the L protein. Plasmids containing the L gene cDNA under control of a bacteriophage T7 promoter were transfected into CV-1 cells which had previously been infected with a recombinant vaccinia virus, vTF7-3, that expresses T7 RNA polymerase. Antigenically authentic L protein was expressed. Using a nucleocapsid transfection assay developed previously, we showed that the transiently expressed L protein had RNA synthesis activity. Site-specific mutations were made in the L cDNA-containing plasmid to change certain amino acids in the putative polymerase domain of the L protein. The effects of these amino acid substitutions on the RNA synthesis activity of the L protein were monitored using the nucleocapsid transfection assay. These experiments showed that residues strictly conserved between the L proteins of different viruses in the family Bunyaviridae were obligatorily required for activity, whereas non-conserved residues could be substituted without abolishing RNA synthesis capability. Our results provide direct evidence for the functional significance of particular amino acids in the polymerase domain of a negative-strand virus RNA polymerase.
Introduction
The L protein of Bunyamwera virus (the prototype of the family Bunyaviridae) has a predicted Mr of 259000 and is a minor, internal component of the virus particle (Elliott, 1989 (Elliott, , 1990 . The bunyavirus L protein (approx. 25 copies per virion) is associated with the N protein (approx. 2100 copies per virion), and with each of the three genomic RNA segments [designated L (large), M (medium) and S (small)], to form ribonucleoprotein complexes termed nucleocapsids (Obijeski et al., 1976) . As with other negative-stranded RNA viruses the bunyavirus nucleocapsid is the template for mRNA synthesis and genome replication (reviewed by Kolakofsky & Hacker, 1991) . The large size of the L protein suggests that it is multifunctional, and most probably catalyses initiation, elongation and termination of RNA synthesis, as well as generating the host ceU-derived RNA oligonucleotides used to prime mRNA transcription (reviewed by Elliott, 1990; Kolakofsky & Hacker, 1991) . In a wide-range, computer-assisted comparison of some 80 RNA polymerases, Poch et al. (1989) described the presence of conserved regions in all these enzymes which they dubbed the 'polymerase motifs'. We have aligned all the available Bunyaviridae L protein sequences and can identify the same motifs; these provide targets for rational site-directed mutagenesis of the L protein.
Recently we described the expression of full-length Bunyamwera virus L protein by recombinant vaccinia viruses and showed that the expressed L protein had RNA synthesis activity in a nucleocapsid transfection assay (Jin & Elliott, 1991) . We have extended these studies and in this paper demonstrate L protein activity in a transient expression system. Furthermore we have produced site-specific amino acid substitutions in the L protein and have assessed the effects of these on RNA synthesis using the nucleocapsid transfection assay. We also describe the production of monospecific antisera raised to portions of the L protein fused to bacterial flgalactosidase, and their characterization by Western blotting and immunoprecipitation.
Methods
Viruses and cells. Bunyamwera virus was grown in BHK cells as described previously (Watret et al., 1985) . Recombinant vaccinia viruses vTF7-3 (which expresses bacteriophage T7 RNA polymerase; Fuerst et al., 1986) , and vSCll-BUNL and vTF7-5BUNL (which 0001-1044 © 1992 SGM contain the Bunyamwera virus L gene cDNA; Jin & Elliott, 1991) were grown in CV-I ceils as described by Mackett et al. (1985) . CV-I cells were maintained in Dulbecco's modified Eagle's medium containing 5% foetal calf serum.
Plasmids. Plasmids containing the full-length L gene cDNA, pTZBUNL and pTF7-5BUNL, were described in Jin & Elliott (1991) . pET8c (Studier et al., 1990) was obtained from Dr C. M. Preston and the pUEX series of plasmids (Bressan & Stanley, 1987) were obtained from Dr D. P. Leader. Plasmids were grown in Escherichia coli strain DH5 and purified by standard techniques (Maniatis et al., 1982) .
To construct pETBUNL, pET8c was digested with Ncol and BamHI, and ligated with complementary synthetic oligonucleotides containing the Bunyamwera virus L gene ATG and nucleotides 54 to 65 of the L gene, to the unique HindllI site in the L gene, followed by Kpnl and BarnHI restriction enzyme sites. Digestion of this plasmid (pETgc H/K) with Hindlll and Kpnl permitted insertion of the remainder of the L gene as a HindllI-KpnI fragment (nucleotides 66 to 6850) from pTZBUNL (Jin & Elliott, 1991) . The resulting plasmid, pETBUNL, contains the complete Bunyamwera virus L gene under control of the T7 promoter and terminator (Jin, 1991) .
Preparation of bacterial fusion proteins.
Portions of the Bunyamwera virus L gene cDNA were cloned into pUEX1 or pUEX3 as summarized in Table 2 . Overnight cultures of E. coil strain DH5 carrying pUEXbased recombinants were diluted 100-fold in 2YT broth, grown at 30 °C to an optical density at 550 nm (OD550) of about 0.2 and then incubated for 2 h and 20 min at 42 °C. Fusion proteins were recovered from 100 ml cultures of bacterial cells as described by Smith et at_ (1990) , and analysed on 10~ SDS-polyacrylamide gels. For preparative purposes gels were stained for 10 min with 0-05% Coomassie blue in water, followed by destaining in water for 10 to 20 min. The fusion protein band was cut from the gel, macerated by extrusion through a 21-gauge needle and suspended in an equal volume of water.
Immunization of rabbits. New Zealand white rabbits (two per fusion protein) were injected subcutaneously with the macerated gel suspension which contained about 0.1 mg of fusion protein on four occasions at 10 day intervals. The rabbits were bled out 10 days after the final injection.
Characterization of" antisera
(i) lmmunoprecipitation. Radiolabelling of infected cells with [3sS]methionine, preparation of cell lysates, formation of immune complexes and analysis of proteins by PAGE were as described in Watret et al. (1985) . Five p.l of anti-fusion protein sera was used in each reaction.
(ii) Western blotting. Bunyamwera virus nucleocapsid proteins were separated by SDS-PAGE and transferred by 'semi-dry electroblotting' to nitrocellulose filters using an LKB NovaBlot transfer apparatus according to the manufacturer's instructions. After incubation with the primary antibody at a 50-fold dilution, the bound antibodies were detected with anti-rabbit lgG-conjugated horseradish peroxidase and reaction with 4-chloro-l-naphthol (both Promega) according to the manufacturer's instructions.
Transient expression of Bunyamwera virus L protein.
Subconfluent monolayers of CV-I cells were infected with vTF7-3 at a multiplicity of 5 p.f.u./cell for 1 h and then transfected with plasmid DNAs using the calcium phosphate precipitation method. Subsequently proteins were labelled with [3 sS]methionine as described above, or total cellular RNA was extracted and analysed by Northern blotting as described previously (Jin & Elliott, 1991) .
Nucleocapsid isolation and transfection assay. Bunyamwera virus nucleocapsids were isolated from infected cells as described previously (Jin & Elliott, 1991) . CV-I cells were infected with vTF7-3 as above and then transfected with a mixture of plasmid DNA and nucteocapsids, essentially following the procedure detailed previously (Jin & Elliott, 1991) . Amplification of the Bunyamwera virus S segment RNA (Jin & Elliott, 1991) was monitored by Northern blotting of RNA extracted 24 h post-transfection.
Site-directed mutagenesis. Site-directed mutagenesis of ssDNA followed the method of Nakamaye & Eckstein (1986) , and used a commercially available kit (Amersham). To facilitate mutagenesis it was considered necessary to work with a fragment of the L cDNA; this fragment should also be easily cloned back into full-length L cDNA after mutagenesis. A 1 kb EcoRI-PstI fragment [nucleotides (nt) 2877 to 3811] covered the appropriate region of the L cDNA but it would have been inconvenient to clone this fragment back into the L cDNA after mutagenesis because of three other EcoRI sites in L. Therefore a silent mutation was made at position 3145 to create an Xhol site; this would allow mutated fragments to be cloned between Xhol and PstI sites in a one-step ligation. Hence the EcoRl--PstI fragment was cloned into similarly digested M13mpl8, and mutated using oligonucleotide L1 (Table 1) to introduce the XhoI site. To reconstruct a full-length L cDNA a four-fragment ligation was set up consisting of the largest StuI/Pstl digestion product of pTF7-5BUNL (the pTF7-5 backbone containing L sequences to the StuI site at position 2315), a StuI-EcoRI (nt 2315 to 2877) fragment of L, the mutated EcoRI-PstI fragment and a PstI (nt 3811 to 6850) fragment of the L cDNA. Correctly reconstructed L clones were identified by restriction enzyme digestion and confirmed by nucleotide sequence analysis using oligonucleotide L2 as a primer and plasmid DNA as template. A clone was selected and designated pTF7-5BUNLXho. For mutagenesis of the polymerase domain the 0.6 kb Xhol-PstI fragment was cloned into pUC119 and ssDNA produced by infecting recombinant plasmid-carrying bacteria with the mutant M13K07 bacteriophage (Vieira & Messing, 1987) . Mutagenesis used the oligonucleotides listed in Table 1 and mutants were identified by nucleotide sequencing. After cloning mutated fragments back into XhoI-PstI digested pTF7-5BUNLXho, the mutations were again confirmed by nucleotide sequencing.
Results

Production of specific antibodies against the Bunyamwera virus L protein
Our approach was to express portions of the L protein as bacterial fusion proteins, and to use these to immunize rabbits. We used the pUEX series of plasmids developed by Bressan & Stanley (1987) ; fragments of the Bunyamwera virus L cDNA were cloned in-frame at the carboxy terminus of the fl-galactosidase gene, which itself is fused at the amino terminus with the promoter, operator and amino terminus of the bacteriophage 2 cro gene. Expression is controlled by the ci857 gene also present in the plasmid, such that temperature shift from 30 °C to 42 °C induces expression of the fl-galactosidase fusion protein. Five fragments of the Bunyamwera virus L cDNA were cloned into the appropriate pUEX vector (Table 2 ) and all constructs were confirmed by sequencing dsDNA using a primer complementary to nucleotides 4101 to 4121 of the pUEX1 DNA (data not shown). Fig. 1 shows expression of the fusion proteins in E. coli strain DH5 transformed with either pUEX3 or the recombinants pUEXL1-L5. All five recombinants induced fusion proteins larger than the parental pUEX3 flgalactosidase; the migration differences correlated with increase in size of the fusion proteins. The fusion proteins were cut out of preparative-scale polyacrylamide gels and used to immunize rabbits (see Methods).
Characterization o[ fusion protein antibodies
Antisera to the five fusion proteins L1-L5 were tested for their reactivity with Bunyamwera virus L protein by Western blotting and radioimmunoprecipitation, and the results are summarized in Table 2 . No reactivity was observed with antisera to L1 and L2, which were raised against short peptides from the L protein (110 and 50 amino acids respectively), in either assay. Antisera to L3 reacted in the Western blot but not in immunoprecipitation, suggesting recognition of denatured rather than the native L protein. Antisera to L4, 214 amino acids near the carboxy terminus of L, reacted in both assays, and antisera to L5, 340 amino acids from the amino terminus of L, reacted by immunoprecipitation.
Transient expression of the Bunyamwera virus L protein
Previously we described the construction of a full-length L gene cDNA and the subsequent expression of functional L protein by using recombinant vaccinia viruses (Jin & Elliott, 1991) . Here we report an alternative approach to express the L protein using the transient plasmid transfection/T7 vaccinia virus system developed by Fuerst et al. (1986) . In this system cells are infected with a recombinant vaccinia virus, vTF7-3, which expresses bacteriophage T7 RNA polymerase, and are then transfected with plasmid DNAs containing the target gene cloned under the control of a T7 promoter. Pattnaik & Wertz (1990 , 1991 have described the elegant use of this system to examine the protein Jin & Elliott (1991) , and p E T B U N L , in which the L c D N A was cloned into the plasmid p E T 8 c (Studier et al., 1990 ) so that the L protein A T G was inserted at the NcoI restriction enzyme site in the vector (Jin, 1991) . Both p T F 7 -5 B U N L and p E T B U N L contain a T7 t e r m i n a t o r d o w n s t r e a m of the L c D N A , whereas p T Z B U N L does not have a T7 t e r m i n a t o r sequence.
Subconfluent monolayers of CV-1 cells were infected with vTF7-3 at a multiplicity of 5, and then transfected with 2 0 g g of the plasmid D N A , as described in Methods. A t 6 h post-transfection the cells were labelled with [3SS]methionine for 16 h and cell lysates were then p r e p a r e d for i m m u n o p r e c i p i t a t i o n using the anti-L4 serum (Fig. 2a) . Full-length L protein was i m m u n o p r e c ipitated from cells transfected with each L-containing plasmid, which m i g r a t e d similarly to the L protein detected in B u n y a m w e r a virus-infected cells. The R N A s m a d e in these transfected cells were analysed by that were infected with only vTF7-3 (lane 3), nor in cells transfected with p T Z B U N L , the construct without the T7 terminator sequence (data not shown). This was surprising because as much L protein was detected with this construct (Fig. 2a, lane 3) as with the others, but may reflect a very heterogeneous population of transcripts in the cells owing to the lack of a T7 termination signal. Further characterization of the system used pTF7-5BUNL. Different amounts (10 to 30 ~g) of D N A were transfected into vTF7-3-infected cells and L protein expression was analysed by immunoprecipitation. As shown in Fig. 3 (a) , there was a direct correlation with the amount of D N A transfected and the amount of L protein expressed, over the range of D N A transfected. The time course of L protein expression was also followed (Fig.  3b) . Maximum levels of L were detected at 4 to 7 h posttransfection and declined rapidly thereafter. The transient expression system provided the opportunity to assess the specificity of the L4 and L5 antisera against full-length and truncated L proteins, pTF7- (Fig. 3c) . Radiolabelled extracts from Bunyamwera virus-infected and vTF7-3-infected (without subsequent transfection) were included as positive and negative controls for L protein expression. The aminoterminal antiserum, L5, precipitated the full-length L protein (lanes 1 and 4) and a protein corresponding in size (approx. Mr 140000) to the truncated L protein synthesized from pTF7-5BUNLAPst (lane 3). In contrast the carboxy-terminal antiserum L4 precipitated only fulllength L (lanes 7 and 8) and not the truncated protein (lane 6). This experiment showed that the two antisera behaved with the expected specificity.
Functional assay of the expressed L protein
Previously we reported an assay which demonstrated that the L protein expressed by recombinant vaccinia viruses was functional in terms of R N A synthesis. Briefly, intracellular nucleocapsids were purified from Bunyamwera virus-infected cells, and transfected into recombinant vaccinia virus-infected cells which expressed the L protein. Amplification of the Bunyamwera virus S R N A was observed using Northern blot analysis of total cellular R N A (Jin & Elliott, 1991) . We used the same protocol to assay the transiently expressed L protein (Fig. 4) . Subsequently the cells were transfected with Bunyamwera virus nucleocapsids (except lane 10). Total cellular RNA was extracted at 20 h post-transfection, separated on a 1 ~ agarose gel, transferred to nitrocellulose membranes and hybridized with a 32p-labelled S segment-specific riboprobe to detect plus-sense Bunyamwera virus RNA. This figure is a composite of separate blots which were hybridized with the S segment probe at the same time, and only the lower part of the autoradiograph is shown.
to generate a series of a m i n o acid substitutions for D 1037 and D 1165 in a single mutagenesis e x p e r i m e n t (Table 3) . A t t e m p t s to mutate K1205 were unsuccessful. The K1205 codon lies within a string of seven A residues and the only mutations found involved deletion of two of these A residues. This a m i n o -t e r m i n a l f r a g m e n t of L was also i m m u n o p r ecipitated after transient expression (Fig. 6a, lane 11) . The ability of the m u t a t e d L proteins to function in the nucleocapsid transfection assay was then m o n i t o r e d (Fig. 6b) and the results are s u m m a r i z e d in Table 3 . The silent m u t a t i o n to create the XhoI site had no effect on R N A synthesis activity c o m p a r e d to the wild-type L protein (Fig. 6b, lanes 13 and 14) . C h a n g i n g D1037 and D l 1 6 5 to each of eight or seven other a m i n o acids essentially abolished activity in the assay (examples shown in lanes 5 to 8); s;milarly no activity was detected when N l l 1 9 was c h a n g ; d to G (lane 3). The a m i n oterminal half of the L protein (N 1119GA3397) was also inactive (data not shown). However changing the nonconserved residues Q1180 to N (lane 1), Q1044 to N (lane 2) RIll8 to Q (lane 4) or Ll150 to V did not affect activity. The SDD triplet in motif C was changed to GDN, the triplet found in all unsegmented negativestrand L proteins (Poch et al., 1989) ; this double mutant was inactive in the transfection assay (lane 12). These results were confirmed by radiolabelling transfected cells with [3SS]methionine and immunoprecipitation of N protein translated from the amplified S segment mRNA (Jin & Elliott, 1991) ; N protein was detected only in cells expressing L proteins designated active in the RNA amplification experiment (data not shown).
Discussion
Until now specific antisera to the Bunyamwera virus L protein were unavailable, mainly because the L protein is not present in large eneugh quantities in infected cells or in virus particles to allow purification. Therefore we exploited the cloned cDNA to the L gene to make bacterial fusion proteins containing portions of the L protein. Of the five fusion proteins produced, two gave rise to useful antisera, which were directed against the amino-and carboxy-terminal regions of the L protein.
From our experience the fusion proteins containing the larger portions of the protein (L3, 199 amino acids; L4, 214 amino acids; L5, 340 amino acids) gave the 'best' response. The antisera to L4 and L5 immunoprecipitated minor amounts of the N protein (e.g. Fig. 2a, lane 1) , and this most probably represents L-N protein interaction in the cell extracts (which were not denatured prior to reaction with the antibodies), perhaps in the form of nucleocapsids. The antiserum prepared against purified Bunyamwera virus (Watret et al., 1985) immunoprecipitated L from Bunyamwera virus-infected cells but not from recombinant vaccinia virus-infected cells that express the L protein (H. Jin & R. M. Elliott, unpublished observations). Thus in this case we suggest that L is precipitated because it is associated with the N protein which is the major antigenic target. The amount of L protein synthesized in Bunyamwera virus-infected or in L plasmid-transfected cells is small, and efficient detection requires long labelling periods with [3SS]methionine ( Fig. 3a and 6a ). With shorter labelling times (Fig. 3b, c ) the L protein is much more difficult to detect, even with specific antisera. However the monospecific L protein antisera we have produced will be invaluable reagents in future experiments on L protein function and intracellular localization, etc.
The longer term aim of our work is to map the functional domains within the L protein. Previously we described expression of the L gene using recombinant vaccinia viruses, and developed an assay which demonstrated that the recombinant L protein had RNA synthesis activity. We have extended this work by expressing the L protein transiently from transfected plasmid DNA, using the vaccinia virus-T7 polymerase system originally described by Fuerst et al. (1986) . A similar regimen has been described by Pattnaik & Wertz (1990 , 1991 for the expression of all the VSV proteins, and these workers have been able to replicate and package a VSV defective-interfering RNA template. We have shown that the transiently expressed Bunyamwera virus L protein is also functional in our assay, although at a lower level than the activity displayed by the L protein expressed by the recombinant vaccinia virus vSCll-BUNL. However the transient system has an advantage if one wants to make many site-directed mutations in the L gene in that it obviates the need to clone the mutated DNA back into a recombinant vaccinia virus, and our initial studies presented above indicate this is a feasible approach.
We chose to make mutations in the putative polymerase domain of the L protein. This region was predicted based on alignment with the polymerase motifs identified by Poch et al. (1989) and by alignment of all the available Bunyaviridae L protein sequences (Fig. 5) . The 'Poch' motifs each contain an (neady) invariant amino acid residue: Asp in motif A, Gly in motif B, Asp-Asp in motif C and Lys in motif D. These residues are all present in the aligned Bunyaviridae L proteins. In motif C the triplet SDD is found; in other polymerases this is usually GDD but in the unsegmented negative-strand viral L proteins this is characteristically GDN. A more thorough discussion of the evolutionary relationships of Bunyaviridae L proteins will be presented elsewhere (R. M. Elliott, unpublished results). Site-specific mutations were made in the putative polymerase domain (Table 3 and Fig. 5 ) and the effects of these changes on the RNA synthesis activity of transiently expressed L protein in the nucleocapsid transfection assay were assessed. Changes to the conserved Asp residues at positions 1037 and 1165 abolished detectable activity in the assay. Converting the SDD triplet in motif C to GDN also abolished activity. Similarly, changing Nll19 (which is conserved in bunyavirus, hantavirus and tospovirus L proteins but not in Rift Valley fever and Uukuniemi phlebovirus L proteins) to a glycine produced an inactive L protein. Changes to four residues not conserved among Bunyaviridae L proteins (Q1044, R1118, L1150 and Q1180) did not affect RNA synthesis activity in the assay. These results have been reproducible in repeated experiments. Some of the mutated L cDNAs have also been cloned into recombinant vaccinia viruses and tested in the nucleocapsid transfection assay; the results were similar to those obtained in the transient assay with the exception of mutant D1037A which showed very low activity (data not shown). We have attempted to make the assay quantitative by using an RNase protection protocol to measure the amount of S segment RNA produced in the transfected cells, but this has not given satisfactory results. Therefore we are only able to score mutated L proteins as positive or negative for RNA synthesis activity based on the Northern blotting results.
To our knowledge there have been no reports on sitedirected mutagenesis of other negative-strand virus L proteins. Mutagenesis has been reported for bacteriophage Qfl and poliovirus RNA polymerases and human immunodeficiency virus reverse transcriptase which contain the motifs (A to D) identified by Pochet al. (1989) . These experiments have highlighted the essential nature of the Asp residue in motif A and the GDD triplet in motif C for polymerase activity (Inokuchi & Hirashima, 1987; Jablonski etal., 1991 ; Boyer et al., 1992 and references therein). Further, Delarue et al. (1990) have proposed that the Asp residues in motifs A and C may be adjacent in a tertiary structure common to all polymerases. Our results provide experimental evidence to support the prediction that the central region of the Bunyamwera virus L protein contains the polymerase domain. More mutagenesis of this region will be required to determine whether the residues conserved between different Bunyaviridae L proteins (e.g. KW in motif A or SS in motif B; see Fig. 5 ) are also required for polymerase activity.
